No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use*
-
Angiotensin II Type 1 Receptor Blockers*
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
-
Antihypertensive Agents / therapeutic use*
-
Benzimidazoles / therapeutic use*
-
Biphenyl Compounds
-
Clinical Trials as Topic
-
Dose-Response Relationship, Drug
-
Drug Therapy, Combination
-
Heart Failure / drug therapy*
-
Heart Failure / mortality
-
Humans
-
Survival Rate
-
Tetrazoles / therapeutic use*
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin II Type 1 Receptor Blockers
-
Angiotensin-Converting Enzyme Inhibitors
-
Antihypertensive Agents
-
Benzimidazoles
-
Biphenyl Compounds
-
Tetrazoles
-
candesartan